Medline has extended its distribution partnership with BioDerm, which gives the company exclusive rights to three additional products under BioDerm's portfolio of urinary management, securement, and skin protection devices.
This agreement demonstrates Medline’s dedication to providing clinically proven urological products that help enhance patient outcomes and experiences while driving best practice among clinicians.
Under the terms of the agreement, Medline has exclusive marketing and distribution rights to acute care facilities in the United States and its protectorates for the following products:
CathGrip: This universal securement device is made from proprietary hydrocolloid that is hypoallergenic and latex free, and the skin-friendly adhesive helps prevent skin tearing and irritation while the patent pending soft straps are designed to reduce pressure injuries.
Freederm: Formulated to instantly remove hydrocolloid, tapes, and bandages, FreeDerm is BioDerm’s trademark proprietary adhesive remover, and is available in spray or ampoule form.
BioPlus+: The proprietary skin prep wipes provide a barrier film layer directly on the skin to improve the adhesion of hydrocolloids, appliances, tapes, and bandages.
Under Medline’s partnership with BioDerm that began in January of this year, the company also exclusively markets and distributes the Men’s Liberty Acute, a male external catheter designed as a means of avoiding Foley catheter and condom catheter use by men within the appropriate patient diagnosis segment.
BioDerm president Gaet Tyranski said: “We couldn’t be more pleased with Medline and our partnership with the Urology division. What started as a single product arrangement has now expanded quickly to our other securement and skin protection lines due to their superior performance and clinical benefits.”
Source: Company Press Release.